Home Business Capital Neimeth Announces Conclusion Of 2.37 Billion Rights Issue
Capital

Neimeth Announces Conclusion Of 2.37 Billion Rights Issue

Share
Share

Neimeth International Pharmaceuticals Plc (the Company) wishes to inform that following close of its Rights Issue exercise on September 15, 2022 that it has received a No-Objection from the Securities and Exchange Commission (SEC) on the allotment of 2,373,947,500 Ordinary Shares at 81.55 per share on the basis of 5 new Ordinary Shares for every 4 Ordinary Shares held as at the close of business on Friday, April 22, 2022. The Rights Issue was fully subscribed, leading to fresh injection of 3.68 billion which will further position the company for growth, improve its capital structure, deleverage its balance sheet, and fund its working capital needs.

The shares allotted will be credited to the CSCS account of allottees by the Registrars to the Issue, in line with the basis of allotment of the shares as approved by the SEC. Allotment of the shares will bring about a change in the Shareholding Structure of the Company. The new Shareholding Structure will be communicated as appropriate once updated.

Share

Businesstoday Magazine

Businesstoday Conference/Awards

Related Articles

Access Holdings Reports 82.8% Growth In Q3 PAT To ₦457.7 billion

*As Total Assets Hit To ₦41.1 Trillion   Access Holdings Plc, one...

CSCS Clinches “Capital Market Infrastructure Developer Of The Year” At BAFI Award 2024

L-R: Frank Aigbogun, Co-founder Business Day, Onome Komolafe, Divisional Head, Business Service...

United Capital Group Takes Home Five Major Awards At 2024 BAFI Awards

L-R: Group Executive Director and Chief Operating Officer, Ayodeji Adigun, Group Chief...

United Capital Grows Profit By 93% yoy

United Capital Group has further cemented its upward growth trajectory, with an...